Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 5,000 shares at $45.62 ($227K) on 2014-02-03, disclosed to the SEC on 2014-02-05.
Scheduled sale ($227k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.24 | 4,057 | $184K | 81.0% |
| 2 | $45.62 | 943 | $43K | 19.0% |
| Total | $45.31 avg | 5,000 | $227K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |